Abstract:As a main subtype of lung cancer, the current situation of non-small cell lung cancer (NSCLC) remains severe worldwide with a 19% survival rate at 5 years. As the conventional therapy approaches, such as chemotherapy, radiotherapy, targeted therapy, and immunotherapy, gradually develop into therapy resistance, searching for a novel therapeutic strategy for NSCLC is urgent. Ferroptosis, an iron-dependent programmed necrosis, has now been widely considered as a key factor affecting the tumorigenesis and progression in various cancers. Focusing on its effect in NSCLC, in different situations, ferroptosis can be triggered or restrained. When ferroptosis was induced in NSCLC, it was available to inhibit the tumor progression both in vitro and in vivo. The dominating mechanism was due to a regulation of the classic ferroptosis-repressed GSH-dependent GPX4 signaling pathway instead of other fractional regulating signal axes that regulated ferroptosis via impacting on the ROS, cellular iron levels, etc. In terms of the prevention of ferroptosis in NSCLC, an GSH-independent mechanism was also discovered, interestingly exhibiting the same upstream as the GPX4 signaling. In addition, this review summarizes the progression of ferroptosis in NSCLC and elaborates their association and specific mechanisms through bioinformatics analysis with multiple experimental evidence from different cascades. Finally, this review also points out the possibility of ferroptosis working as a novel strategy for therapy resistance in NSCLC, emphasizing its therapeutic potential.

Advances in ferroptosis in head and neck cancer (Review)

Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments

Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review)

Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Advances in ferroptosis of cancer therapy

Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach

Ferroptosis in cancer (Review)

Current Progress of Ferroptosis Study in Hepatocellular Carcinoma

Recent advances of ferroptosis in tumor: From biological function to clinical application

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

Ferroptosis and its emerging role in tumor

The role of ferroptosis in radiotherapy and combination therapy for head and neck squamous cell carcinoma (Review)

Ferroptosis: insight into the treatment of hepatocellular carcinoma

Ferroptosis in hepatocellular carcinoma: from bench to bedside

Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It

Ferroptosis as a potential target for cancer therapy

Ferroptosis resistance in cancer: recent advances and future perspectives

Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer

A Promising Future of Ferroptosis in Tumor Therapy

Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology